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Abstract
Background: This study describes a strategy to select and isolate spontaneous riboflavin-
overproducing strains of Lactobacillus (Lb.) plantarum, Leuconostoc (Lc.) mesenteroides and
Propionibacterium (P.) freudenreichii.
Results: The toxic riboflavin analogue roseoflavin was used to isolate natural riboflavin-
overproducing variants of the food grade micro-organisms Lb. plantarum, Lc. mesenteroides and P.
freudenreichii strains. The method was successfully employed for strains of all three species. The
mutation(s) responsible for the observed overproduction of riboflavin were identified for isolates
of two species.
Conclusion: Selection for spontaneous roseoflavin-resistant mutants was found to be a reliable
method to obtain natural riboflavin-overproducing strains of a number of species commonly used
in the food industry. This study presents a convenient method for deriving riboflavin-overproducing
strains of bacterial starter cultures, which are currently used in the food industry, by a non-
recombinant methodology. Use of such starter strains can be exploited to increase the vitamin
content in certain food products.
Background
The term "nutraceutical" was first coined in 1989 as a con-
traction of the words "nutrition" and "pharmaceutical",
and refers to a food compound that not only supplements
the diet but also aids in the prevention and/or treatment
of disease and/or disorder [1]. Similarly, functional foods
contain at least one component, whether it be a nutrient
or not, that affects a target function of the organism in a
specific, positive way, thereby generating a physiological
effect beyond its nutritional value [2]. Functional food
ingredients include probiotics, prebiotics, vitamins and
minerals, and can be found in such diverse products as
fermented dairy products, sports drinks and chewing gum
[3,4]. Interest in and acceptance of functional foods is
gaining impetus, for a number of reasons that include
changing consumer demands and social attitudes, scien-
tific evidence of the health benefits of particular ingredi-
ents and commercially driven interests to add value to
existing products. Consumer awareness on nutrition
raises the demand for healthy food options, ideally deliv-
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nificant and growing global market with recent estimates
indicating up to a $50 billion annual share [4].
Since Metchnikoff first theorised that fermented milk
products provided health benefits, including longer life
expectancy, these products have been viewed as "healthy"
by consumers [6]. In many modern societies fermented
dairy products make up a substantial proportion of the
total daily food consumption. Lactic acid bacteria (LAB)
are an industrially important group of micro-organisms
used all over the world for centuries in a large variety of
food fermentations, such as those of meat and vegetables,
but undoubtedly with the major application in the dairy
industry. LAB have been shown to be ideal cell factories
because the biosynthetic capacity and metabolic versatil-
ity of these bacteria is generally quite limited, their physi-
ology is relatively simple, while their energy metabolism
and biosynthesis processes are almost completely sepa-
rated [7]. It has therefore been possible to exploit LAB for
the production of many nutraceuticals [8]. The dairy pro-
pionibacteria, especially P. freudenreichii ssp. shermanii,
are the main ripening flora in Swiss-type cheeses, where
they play a critical role in the development of the charac-
teristic flavour and "eye" production [9]. Propionibacteria
are also used for the production of vitamin B12 [10] and
there is increasing interest in their potential use as probi-
otics [11]. Considering the current widespread use of LAB
and propionibacteria in the food industry, coupled with
consumer demand for healthier foods, the potential to
use these food grade microorganisms as "vitamin facto-
ries" was investigated.
Riboflavin is a water-soluble vitamin produced by plants
and many micro-organisms. However, this biosynthetic
capability is lacking in higher animals and they must
therefore obtain this essential nutrient from their diet.
Riboflavin is the precursor of the enzyme cofactors FMN
and FAD, which are vital in many of the body's enzymatic
functions for the transfer of electrons in oxidation-reduc-
tion reactions. Riboflavin deficiency is most commonly
seen in developing countries [12], among the elderly [13],
and in chronic alcoholics [14]. Clinical symptoms of ribo-
flavin deficiency are rarely seen in developed countries
but the subclinical stage of deficiency, characterised by a
change in biochemical indices, is seen in a significant por-
tion of the population of these nations as exemplified by
Ireland [15]. Riboflavin deficiency mainly manifests itself
clinically in the mucocutaneous surfaces of the mouth,
through the occurrence of cracks at the corners, and
inflammation of the lips and tongue [16], but deficiency
is also associated with vision deterioration and growth
failure. In recent years the vitamin has been found to be
effective in the treatment of migraine [17], malaria [18]
and Parkinson's disease [19]. Riboflavin is commonly
obtained in the diet from meat, eggs, fortified cereals and
green leafy vegetables, in addition to dairy products,
which contribute most significantly to riboflavin intake
[20].
Riboflavin has been traditionally synthesised for food and
feed fortification by chemical means but in more recent
years biotechnological processes employing various bac-
teria, yeast and fungi have been found to be commercially
competitive and are replacing chemical synthesis [21].
One of these biotechnological processes employs Bacillus
(B.) subtilis as the riboflavin cell factory and much work
has been carried out in characterising the vitamin's bio-
synthetic pathway in this organism (For a review see [22]).
For B. subtilis and Lactococcus (L.) lactis it has been shown
that mutants that are isolated on the basis of their resist-
ance to the toxic riboflavin analogue roseoflavin also
exhibit a riboflavin-overproduction phenotype [23,24].
Recently, it was demonstrated that fermented dairy prod-
ucts produced either with a roseoflavin-resistant strain of
P. freudenreichii or L. lactis, was able to improve growth
and riboflavin status of riboflavin-depleted animals
[25,26].
The current study reports on the isolation of roseoflavin-
resistant mutants of various strains used in the food
industry and analysis of their resulting riboflavin-overpro-
ducing phenotype. In the case of Lb. plantarum and Lc.
mesenteroides the mutations responsible for riboflavin
overproduction were identified and the possible effects of
these mutations on transcription of the rib operon are dis-
cussed. In the case of P. freudenreichii the riboflavin-over-
producing strains were examined in comparison to a
control strain in a yoghurt production model.
Results
Isolation of roseoflavin resistant Leuconostoc 
mesenteroides
It has previously been shown in B. subtilis and L. lactis that
spontaneous resistance to the toxic riboflavin analogue,
roseoflavin, frequently coincides with a riboflavin-over-
producing phenotype [24,27]. In order to determine
whether this method was also applicable to Lc. mesenter-
oides, a wildtype strain of this species was plated at mid
exponential growth phase on CDM containing 100 mg/L
roseoflavin. In this way a total eleven mutants were iso-
lated. These isolates were grown in CDM and as the cells
entered the stationary phase the cell free supernatant was
analysed for riboflavin content. All eleven roseoflavin-
resistant mutants were found to be riboflavin overproduc-
ers (Fig. 1), leading to accumulation of the vitamin into
the medium although at clearly different levels ranging
from 120 to 500 μg/L.Page 2 of 12
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overproduction
B. subtilis roseoflavin-resistant mutants have been shown
to carry mutations either in the regulatory region of the rib
operon or in ribC, encoding the flavokinase/FAD syn-
thetase responsible for the conversion of riboflavin to its
active derivatives FMN and FAD [28-30]. Roseoflavin
resistance in L. lactis seems to be due to mutations that
reside exclusively in the regulatory region upstream of the
rib operon [24]. It has been found that this region acts as
a riboswitch causing premature transcription termination
of the rib operon in the presence of FMN [31]. The RFN
element is a highly conserved domain found within this
5'-untranslated region consisting of 5 stem-loop struc-
tures [32]. A predicted RFN element was identified
upstream of the Lc. mesenteroides rib operon using RFAM
(indicated in Fig. 2). To investigate whether mutations
were present in the homologous DNA regions in the rose-
oflavin-resistant Lc. mesenteroides mutants chromosomal
DNA was isolated from each mutant after which the rele-
vant regions were amplified by PCR and subjected to
sequence analysis. No mutations were identified in the
ribC gene, whereas in each of the isolated mutants the rib
leader region [Genbank: DQ645591] was shown to con-
tain a mutation (Fig. 2). In only one case (CB203) the
mutation was represented by a deletion, while the other
ten strains were shown to possess point mutations at one
of four different locations within the rib leader region. At
two of these locations different mutations occurred in dif-
ferent mutants (For example, the rib leader region of
mutant CB201 contains a G to A substitution at position
77, while strain CB207 contains a G to C substitution at
the corresponding position).
Isolation of riboflavin-overproducing Lb. plantarum and 
identification of mutations resulting in riboflavin 
overproduction
Bioinformatic analysis had previously shown that the
sequenced strain of Lb. plantarum WCFS1 contains an
incomplete rib operon, in which the entire ribG and part
of ribB are absent from the genome [24,33]. As expected,
this strain is unable to grow in the absence of riboflavin
(Fig. 3(A)), in contrast to Lb. plantarum NCDO1752,
which is capable of growth in the absence of the vitamin,
thus indicating that this strain encodes a complete and
functional riboflavin biosynthetic capability. The latter
strain was exposed to 100 mg/L roseoflavin resulting in
the isolation of six resistant mutants, which were also
shown to be riboflavin overproducers (Fig. 4). In order to
analyse the possible mutations in these mutants it was
necessary to obtain the sequence of the region upstream
of ribG, which is not present in the sequenced strain. PCR
and sequence analysis of this region from NCDO1752
suggests that the WCFS1 genome harbours a deletion of
approximately 1350 base pairs corresponding to the
entire ribG gene, and part of ribB (Figs. 3(B) and 3(C)).
The sequence of the regulatory region in NCDO1752 was
determined [Genbank: DQ645592], allowing the identifi-
cation of the putative RFN element using RFAM. This
region was then amplified by PCR from the riboflavin-
overproducing mutants and their sequence was deter-
mined. Only two types of mutations were found (Fig. 5).
One strain (CB300) contained a G to T substitution, while
the remaining strains (CB301 to 305) contained a 9 base
pair deletion within the RFN element.
Isolation of roseoflavin-resistant Propionibacterium 
freudenreichii
Two different strains of P. freudenreichii were selected in
order to investigate whether the roseoflavin-resistance
strategy for the isolation of riboflavin overproducers
could also be applied to a representative species of a high-
GC gram-positive bacterium. The method was indeed suc-
cessful as shown by the isolation of twelve riboflavin over-
producing mutants of this species, each varying in the
amount of riboflavin produced (Fig. 6). Since the genome
sequence of P. freudenreichii is not publicly available and
the amplification of the rib leader region of this species
using degenerate primers based on the rib leader sequence
of P. acnes was unsuccessful, it was not possible to deter-
mine the nature of the mutation(s) resulting in the altered
phenotype.
Stability study of riboflavin overproducing phenotype in P. 
freudenreichii
In order for any of the strains isolated in this study to have
potential industrial usefulness it is necessary that the ribo-
flavin-overproducing phenotype is stably maintained. To
determine if this is the case, P. freudenreichii NIZO B374
Riboflavin produced by roseoflavin-resistant Lc. mesenteroides NCDO2028 m tantsF gure 1
Riboflavin produced by roseoflavin-resistant Lc. mesenteroides 
NCDO2028 mutants. The riboflavin concentration was 
determined in the cell free supernatant as the cells entered 
stationary phase. The various patterns indicate different 
mutations.
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subcultured for sixty generations in the absence of the
riboflavin analogue roseoflavin and extracellular ribofla-
vin was determined throughout. It was found that the
riboflavin-overproducing phenotype is stably maintained
in the absence of the selection pressure for at least 60 gen-
erations (Fig. 7).
Yoghurt study using P. freudenreichii B374 and its 
riboflavin-overproducing derivative B2336
In order to determine if the cultures isolated in this study
could have industrial potential, a yoghurt production trial
was set up, which compared the use of P. freudenreichii
NIZO B374 and its riboflavin-overproducing derivative P.
freudenreichii NIZO B2336. To optimize the effect of pro-
pionibacteria in a yoghurt fermentation, we compared
two different fermentation processes. The effect of co-
inoculation of the propionibacteria with the yoghurt
starter culture was compared with pre-fermentation by the
propionibacteria prior to the addition of the yoghurt
starter culture. The viable counts of propionibacteria,
streptococci and lactobacilli were unaffected by the pres-
ence of the wildtype or riboflavin-overproducing propi-
onibacterial strain. Also sequential inoculation or co-
inoculation was did not affect viable counts of the differ-
ent strains in the starter culture (data not shown). The
final pH after fermentation is an important parameter in
the yoghurt production process. Figure 8(A) shows the
final pH value of the yoghurt at various inoculum levels
using both the wildtype and riboflavin-overproducing
strains in both sequential and simultaneous inoculation.
Both strains have the same effect on acidification of the
yoghurt. However, a marked difference is visible between
the types of inoculation. Preculturing with propionibacte-
ria counteracts acidification, while no effect was observed
when the propionibacteria were added simultaneously
Alignment of the rib operon regulatory region of Lc. mesenteroides NCDO2028 and seven different mutants isolatedFigure 2
Alignment of the rib operon regulatory region of Lc. mesenteroides NCDO2028 and seven different mutants isolated. The muta-
tions are shaded. The predicted -10 and -35 recognition sequences and ribosomal binding site are boxed. The ribG start codon 
is boxed with dashed lines. The RFN element predicted by RFAM is indicated by the arrows below the sequence.
T T G A C A T T G T A G A A T T C T A A T G A T A A A T T A G T T T T G T T A A A T A A T T T A A T C T T C G G G G C A  1 NCDO2028.
T T G A C A T T G T A G A A T T C T A A T G A T A A A T T A G T T T T G T T A A A T A A T T T A A T C T T C G G G G C A  1 CB200.seq
T T G A C A T T G T A G A A T T C T A A T G A T A A A T T A G T T T T G T T A A A T A A T T T A A T C T T C G G G G C A  1 CB201.seq
T T G A C A T T G T A G A A T T C T A A T G A T A A A T T A G T T T T G T T A A A T A A T T T A A T C T T C G G G G C A  1 CB202.seq
T T G A C A T T G T A G A A T T C T A A T G A T A A A T T A G T T T T G T T A A A T A A T T T A A T C T T C G G G G C A  1 CB203.seq
T T G A C A T T G T A G A A T T C T A A T G A T A A A T T A G T T T T G T T A A A T A A T T T A A T C T T C G G G G C A  1 CB206.seq
T T G A C A T T G T A G A A T T C T A A T G A T A A A T T A G T T T T G T T A A A T A A T T T A A T C T T C G G G G C A  1 CB207.seq
T T G A C A T T G T A G A A T T C T A A T G A T A A A T T A G T T T T G T T A A A T A A T T T A A T C T T C G G G G C A  1 CB208.seq
G G G T G T A T T C C C G A C C G A C G G T G A T G G T G A A T A A C C T C A G T C C G T G A C C C G C G A T A T T T T  61 NCDO2028.
G G A T G T A T T C C C G A C C G A C G G T G A T G G T G A A T A A C C T C A G T C C G T G A C C C G C G A T A T T T T  61 CB200.seq
G G G T G T A T T C C C G A C C A A C G G T G A T G G T G A A T A A C C T C A G T C C G T G A C C C G C G A T A T T T T  61 CB201.seq
G G G T G T A T T C C C G A C C G A C G G T G A T G G T G A A T A A C C T C A G T C C G T G A C C C G C G A T A T T T T  61 CB202.seq
G G G T G T A T T C C C G A C C G A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  61 CB203.seq
G G G T G T A T T C C C G A C C G A C G G T G A T G G T G A A T A A C C T C A G T C C G T G A C C C G C G A T A T T T T  61 CB206.seq
G G G T G T A T T C C C G A C C C A C G G T G A T G G T G A A T A A C C T C A G T C C G T G A C C C G C G A T A T T T T  61 CB207.seq
G G G T G T A T T C C C G A C C G A C G G T G A T G G T G A A T A A C C T C A G T C C G T G A C C C G C G A T A T T T T  61 CB208.seq
C G C G G T T G A C A C A G T G A A A T T C T G T G A C C G A C A G T T A A A G T C T G G A T G G G A G A A G A T T T G  121 NCDO2028.
C G C G G T T G A C A C A G T G A A A T T C T G T G A C C G A C A G T T A A A G T C T G G A T G G G A G A A G A T T T G  121 CB200.seq
C G C G G T T G A C A C A G T G A A A T T C T G T G A C C G A C A G T T A A A G T C T G G A T G G G A G A A G A T T T G  121 CB201.seq
C G C G G T T G A C A C A G T G A A A T T C T G T G A C C G A C A G T T A A A T T C T G G A T G G G A G A A G A T T T G  121 CB202.seq
- - - - - - - - - - - - - G T G A A A T T C T G T G A C C G A C A G T T A A A G T C T G G A T G G G A G A A G A T T T G  79 CB203.seq
C G C G G T T G A C A C A G T G A A A T T C T G T G A C C G A C A G T T G A A G T C T G G A T G G G A G A A G A T T T G  121 CB206.seq
C G C G G T T G A C A C A G T G A A A T T C T G T G A C C G A C A G T T A A A G T C T G G A T G G G A G A A G A T T T G  121 CB207.seq
C G C G G T T G A C A C A G T G A A A T T C T G T G A C C G A C A G T T A A A A T C T G G A T G G G A G A A G A T T T G  121 CB208.seq
A A A T A G T T T A G A C G A T G C T T T T T T A G A T T G T C T A G G T T T T T T G A A T T A A T C T A A A C T A C T  181 NCDO2028.
A A A T A G T T T A G A C G A T G C T T T T T T A G A T T G T C T A G G T T T T T T G A A T T A A T C T A A A C T A C T  181 CB200.seq
A A A T A G T T T A G A C G A T G C T T T T T T A G A T T G T C T A G G T T T T T T G A A T T A A T C T A A A C T A C T  181 CB201.seq
A A A T A G T T T A G A C G A T G C T T T T T T A G A T T G T C T A G G T T T T T T G A A T T A A T C T A A A C T A C T  181 CB202.seq
A A A T A G T T T A G A C G A T G C T T T T T T A G A T T G T C T A G G T T T T T T G A A T T A A T C T A A A C T A C T  126 CB203.seq
A A A T A G T T T A G A C G A T G C T T T T T T A G A T T G T C T A G G T T T T T T G A A T T A A T C T A A A C T A C T  181 CB206.seq
A A A T A G T T T A G A C G A T G C T T T T T T A G A T T G T C T A G G T T T T T T G A A T T A A T C T A A A C T A C T  181 CB207.seq
A A A T A G T T T A G A C G A T G C T T T T T T A G A T T G T C T A G G T T T T T T G A A T T A A T C T A A A C T A C T  181 CB208.seq
A T A A A C C C G A T G T G T A T T T T T A A C G C A T C G G G T T T T T T G T C C T G A A A A A T T C A G G A G G T A  241 NCDO2028.
A T A A A C C C G A T G T G T A T T T T T A A C G C A T C G G G T T T T T T G T C C T G A A A A A T T C A G G A G G T A  241 CB200.seq
A T A A A C C C G A T G T G T A T T T T T A A C G C A T C G G G T T T T T T G T C C T G A A A A A T T C A G G A G G T A  241 CB201.seq
A T A A A C C C G A T G T G T A T T T T T A A C G C A T C G G G T T T T T T G T C C T G A A A A A T T C A G G A G G T A  241 CB202.seq
A T A A A C C C G A T G T G T A T T T T T A A C G C A T C G G G T T T T T T G T C C T G A A A A A T T C A G G A G G T A  186 CB203.seq
A T A A A C C C G A T G T G T A T T T T T A A C G C A T C G G G T T T T T T G T C C T G A A A A A T T C A G G A G G T A  241 CB206.seq
A T A A A C C C G A T G T G T A T T T T T A A C G C A T C G G G T T T T T T G T C C T G A A A A A T T C A G G A G G T A  241 CB207.seq
A T A A A C C C G A T G T G T A T T T T T A A C G C A T C G G G T T T T T T G T C C T G A A A A A T T C A G G A G G T A  241 CB208.seq
A G T A T G                                                        301 NCDO2028.
A G T A T G                                                        301 CB200.seq
A G T A T G                                                        301 CB201.seq
A G T A T G                                                        301 CB202.seq
A G T A T G                                                        246 CB203.seq
A G T A T G                                                        301 CB206.seq
A G T A T G                                                        301 CB207.seq
A G T A T G301 CB208.seq
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Microbial Cell Factories 2006, 5:24 http://www.microbialcellfactories.com/content/5/1/24with the starter culture. Figure 8(B) shows the final ribo-
flavin concentration of the yoghurt at various inoculum
levels of P. freudenreichii NIZO B374 and its riboflavin-
overproducing derivative P. freudenreichii NIZO B2336.
Co-inoculation of the propionibacteria with the starter
culture has little impact on final riboflavin levels. How-
ever, addition of P. freudenreichii NIZO B2336 in the
sequential fermentation process shows a doubling of the
concentration of riboflavin in the fermented end-product.
Discussion
The work presented in this study demonstrates the broad
applicability of the strategy to isolate strains with
enhanced vitamin B2 production characteristics using
sub-inhibitory levels of roseoflavin. The resultant strains
are made through a non-recombinant method and may
therefore be readily applicable in an industrial setting.
Various biotechnological processes have been developed
for industrial scale riboflavin biosynthesis using the asco-
mycetes Ashbya gossypii, different yeasts and the bacterium
B. subtilis [21]. The latter organism has been successfully
employed at a commercial scale to produce riboflavin for
feed and food fortification purposes. However, since this
production procedure involved a genetically recombinant
organism regulatory approval was required where sub-
stantial equivalence of the product to non-recombinant
riboflavin had to be established, while no DNA from the
production strain was allowed to be present in the final
product [34]. The purpose of the present study was not to
develop strains which would challenge these already
(A) Growth of Lb. plantarum NCDO 1752 (black lines with circles) and Lb. plantarum WCFS1 (red lines with triangles) in CDM solid lines, closed symbols) or M +  μM riboflavin (dashed lines, open symbols)Figure 3
(A) Growth of Lb. plantarum NCDO 1752 (black lines with circles) and Lb. plantarum WCFS1 (red lines with triangles) in CDM 
(solid lines, closed symbols) or CDM + 5 μM riboflavin (dashed lines, open symbols) (B) Amplification of the region from 
lp_1345 to the C terminal of ribB from Lb. plantarum strains chromosomal DNA. Lane 1: Molecular weight marker; Lane 2: Lb. 
plantarum WCFS1; Lane 3: Lb. plantarum NCDO 1752; Lane 4: negative control (H2O). The size of the marker bands are indi-
cated to the left of the picture. (C) Schematic diagram of the deleted region in Lb. plantarum WCFS1 in comparison to Lb. 
plantarum NCDO 1752.
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Microbial Cell Factories 2006, 5:24 http://www.microbialcellfactories.com/content/5/1/24available processes, but rather to look at the potential to
isolate strains with an improved riboflavin production
phenotype that could replace the riboflavin-consuming
parent strains in traditional food fermentation processes
thus improving the bioavailability of riboflavin.
The Lc. mesenteroides strain, NCDO 2028 used in this
study was originally isolated from beetroot silage, and was
chosen as a representative of a species, which has many
varied industrial applications in the dairy industry and
various plant and vegetable fermentation processes [35-
37]. Lb. plantarum, used in a large number of fermentation
processes was chosen as another candidate. This organism
is found in many diverse environments, owing to its met-
abolic flexibility [38]. In general, descriptions of the
strain's nutritional requirements indicate that riboflavin is
not required for growth, indicative of a functional ribofla-
vin biosynthetic pathway [39]. Lb. plantarum NCDO
1752, a pickled cabbage isolate, is capable of growth in
the absence of the vitamin illustrating its ability to synthe-
sise the vitamin. However, in the course of this work it was
revealed that the sequenced strain of Lb. plantarum,
WCFS1 does not contain a functional rib operon and con-
sequently is unable to grow in the absence of exogenous
riboflavin [40]. Two strains of P. freudenreichii (both iso-
lated from cheese), one subspecies freudenreichii (NIZO
B374) and one subspecies shermanii (NIZO B369) were
selected from the NIZO culture collection and the resist-
ance strategy was applied also to this strain. All isolated
mutants from these two subspecies were shown to be
riboflavin overproducers. The successful application of
the roseoflavin resistance strategy in three diverse bacte-
rial species shows that it is a readily employable system in
an industrial setting to isolate starter strains that produce
and secrete vitamin B2. This is particularly appealing
when one considers that some yoghurt cultures have been
shown to actually decrease the concentration of riboflavin
in some products due to their consumption of the vitamin
[41]. In a simultaneously performed collaborative study it
was demonstrated that a fermented dairy product pro-
duced with P. freudenreichii B2336 was able to improve
growth and riboflavin status of riboflavin-depleted ani-
mals [25]. This proves that the riboflavin produced in
yoghurt fermentation is available as a nutrient.
Although not all spontaneous or induced mutations caus-
ing riboflavin overproduction in B. subtilis have been ana-
lysed in detail, the characterised roseoflavin-induced
mutations in this organism have been located either in
ribC, the bifunctional flavokinase/FAD synthetase, which
converts riboflavin to FMN and FAD [28,30], or in the reg-
ulatory region upstream of the rib operon [29]. This
knowledge facilitated the identification of the mutations
present in the roseoflavin-resistant LAB strains. No muta-
tions were identified in the ribC homologue of any of the
roseoflavin-resistant strains, but instead all characterised
mutants were found to contain mutations in the regula-
tory leader region upstream of the rib operon. In both spe-
cies different point mutations were identified, which were
shown to differentially affect the level of riboflavin over-
production. Additionally, for both LAB species spontane-
ous roseoflavin-resistant mutants were isolated
containing various deletions in the regulatory region of
the rib operon. It is expected that such mutations are
extremely stable. Furthermore, in P. freudenreichii it was
shown that after sixty generations in non-selective media
the riboflavin-overproducing phenotype does not revert
to the wildtype phenotype. In analogy to what is known
for the regulation of riboflavin biosynthesis in B. subtilis
and L. lactis [24,31,42] it is assumed that also in the spe-
cies used in this study regulation of the rib operon would
be mediated by a termination-antitermination mecha-
nism resulting from two different folding options of the
RFN element upstream of the operon in response to ribo-
flavin or FMN. RFN elements have been identified in the
rib operon leader region of Lc. mesenteroides (Fig. 2) and
Lb. plantarum (Fig. 5) using RFAM [43]. It is likely from the
position of the mutations that they affect the stability of
the terminator structure making it less energetically
favourable for it to form, thus allowing continued tran-
scription of the rib operon.
In order to study the potential usefulness of such strains
in an industrial setting a pilot yoghurt trial was set up to
compare addition of P. freudenreichii NIZO B374 or its
riboflavin-overproducing derivative B2336 either 24
Riboflavin produced by roseoflavin-resistant Lb. plantarum NCDO1752 m tantsF gure 4
Riboflavin produced by roseoflavin-resistant Lb. plantarum 
NCDO1752 mutants. The riboflavin concentration was 
determined in the cell free supernatant after the cells 
entered stationary phase. The two shades represent the two 
mutants isolated.
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taneously with the starter culture. Sequential addition of
strain NIZO B2336 to the yoghurt was found to double
the concentration of riboflavin in the final product in
comparison to yoghurt containing the non-producing
wildtype propionibacterium. Furthermore, the mutant
showed no differences in comparison to the wildtype
strain regarding final cell numbers of the starter culture or
final pH of the product. This illustrates that there is a clear
benefit of using such riboflavin-overproducing strains in
fermentations as it increases the vitamin content of the
final product, thus making it more appealing to consum-
ers. Sequential inoculation of the propionibacteria was
also found to counteract acidification resulting in a milder
product, which could be used as another positive selling
point.
The basic concepts of nutrition are changing. The tradi-
tional idea of an 'adequate diet', which provides enough
nutrients to ensure the individual's survival and meet met-
abolic needs as well as satisfying hunger is now obsolete.
More and more emphasis is being placed on the need for
foods to promote health, improve well being and reduce
the risk of illness through the adoption of the concept of
an "optimum diet" [2]. Selection of strains that have been
subjected to uncontrolled genetic alterations has been
used in the dairy industry to improve certain intrinsic
characteristics of the fermented end product. For example,
a spontaneous IS element mediated deletion of the lacZ
gene altered lactose metabolism resulting in a decreased
fermentation of the sugar. Yoghurt made using this strain
is not affected by further acidification [44]. Strains modi-
fied by induced mutations are considered non-GMO and
Alignment of the rib operon regulatory region of Lb. plantarum NCDO1752 and the two mutants isolatedFigure 5
Alignment of the rib operon regulatory region of Lb. plantarum NCDO1752 and the two mutants isolated. The mutations are 
shaded. The predicted -10 and -35 recognition sequences and ribosomal binding site are boxed. The ribG start codon is boxed 
with dashed lines. The RFN element predicted by RFAM is indicated by the arrows below the sequence.
T T G A C A A T T G A T T A A G A A A G T G T T T T T A T A A A A G G T G A A A A C T G A A T A C G  1 NCDO1
T T G A C A A T T G A T T A A G A A A G T G T T T T T A T A A A A G G T G A A A A C T G A A T A C G  1 CB300
T T G A C A A T T G A T T A A G A A A G T G T T T T T A T A A A A G G T G A A A A C T G A A T A C G  1 CB301
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Union [45]. Such strategies could have important implica-
tions for food fermentations as industry constantly strives
to increase the marketability of their products to more
health conscious consumers in an increasingly competi-
tive market.
Methods
Bacterial strains, media and culture conditions
The bacterial strains and plasmids used in this study are
listed in Table 1. Lc. mesenteroides and Lb. plantarum were
routinely grown in MRS medium [46] or in chemically
defined medium (CDM) (adapted by removal of folic
acid, riboflavin and nucleotides) [47,48]. P. freudenreichii
strains were routinely cultured in Lactate Broth (LB) con-
taining tryptone (5 g/L), yeast extract (10 g/L), Na-ace-
tate.3H2O (8 g/L) and Na-lactate molasses 60% (25 g/L)
at 30°C. The pH of the medium was adjusted to pH 6.5
with 1N KOH before heat treatment for 15 min. at 121°C.
The chemically defined medium (CDM) described by Jan
et al. [49] was modified for the selection of roseoflavin-
resistant mutants. The following ingredients were omit-
ted: p-aminobenzoic acid, folic acid, riboflavin, L-pheny-
lalanine, L-tryptophane, and L-tyrosine. Enumeration of
propionibacteria was done on lactate broth agar plates.
Isolation of roseoflavin-resistant mutants and sequence 
analysis of roseoflavin-resistant mutants
Spontaneous roseoflavin-resistant mutants of Lb.
plantarum and Lc. mesenteroides were isolated by plating
mid logarithmic phase cells on CDM containing 100 mg
l-1 roseoflavin. Isolation of chromosomal DNA from Lc.
mesenteroides and Lb. plantarum was performed as
described by Leenhouts et al. [50,51]. In order to identify
the mutations that were the probable cause of roseoflavin
resistance and riboflavin overproduction the regulatory
region upstream of ribG was amplified by PCR, purified
using the JETquick PCR purification kit (Genomed,
Löhne, Germany) and subjected to sequence analysis
(MWG Biotech AG, Ebersberg, Germany). Spontaneous
Riboflavin produced by roseoflavin-resistant P. freudenreichii B374 mutantsF gure 6
Riboflavin produced by roseoflavin-resistant P. freudenreichii B374 mutants. The riboflavin concentration was determined in the 
cell free supernatant after the cells entered stationary phase. The solid bars represent the levels produced by the roseoflavin-
resistant strains, while the open bars represent the wildtype strain concentrations.Page 8 of 12
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were isolated by plating cultures on adapted chemically
defined medium (see above) on solid medium made of
the same chemically defined medium supplemented with
1% agar and 10 mg/L roseoflavin. After prolonged incuba-
tion at 30°C, roseoflavin-resistant colonies were isolated
from the plates and further cultured on liquid chemically
defined medium supplemented with 10 mg/L roseoflavin.
Fully grown cultures were subsequently diluted in fresh
medium in which the roseoflavin concentration was step-
wise increased from 50 mg/L, then to 100 mg/L and
finally to 200 mg/L. From the final culture with 200 mg/L
roseoflavin, single colonies were isolated, and analysed
for riboflavin production.
Bioinformatics
In Lc. mesenteroides and Lb. plantarum potential RFN ele-
ments were identified using RFAM, which is a collection
of multiple sequence alignments and covariance models
representing non-coding RNA families [43,52].
Quantitative analysis of riboflavin in culture medium
Extracellular riboflavin concentrations were measured by
reverse phase HPLC. A Ultrasphere RP 4.6 mm × 25 cm
column (Beckman Coulter, Fullerton, CA) was used and
riboflavin was eluted with a linear gradient of acetonitrile
from 3.6% to 30% at pH 3.2. Fluorescent detection was
used and the excitation and emission wavelengths were
440 and 520 nm, respectively. Commercially obtained
riboflavin and FMN were used as references and to obtain
a standard curve for quantitative purposes (Sigma, Stein-
heim, Germany).
Stability study of riboflavin overproducing phenotype in P. 
freudenreichii
P. freudenreichii B374 and its riboflavin-overproducing
derivatives were subcultured in lactate broth lacking rose-
oflavin for 60 generations and extracellular riboflavin lev-
els were measured every 10 generations to determine the
stability of the riboflavin-overproducing phenotype.
Yoghurt study using P. freudenreichii NIZO B374 and its 
riboflavin-overproducing derivative P. freudenreichii NIZO 
B2336
Two different methods were applied to produce yoghurt
with propionibacteria. First the pasteurized milk was fer-
mented by simultaneous addition of a traditional yoghurt
starter culture NIZO S737 (inoculation level of 0.2%) and
Propionibacterium freudenreichii NIZO B374 (wildtype) or
P. freudenreichii NIZO B2336 (riboflavin-overproducing
Riboflavin produced by P. freudenreichii B374 and its riboflavin overproducing derivatives B2336 and B374.21 after successive gener tions in roseoflavin free brothF gu e 7
Riboflavin produced by P. freudenreichii B374 and its riboflavin overproducing derivatives B2336 and B374.21 after successive 
generations in roseoflavin free broth.Page 9 of 12
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milk was subsequently incubated for 16 hours at 30°C. P.
freudenreichii NIZO B374 or NIZO B2336 were added at
various inoculum levels (0, 1, 2, 5, 10 or 20%). Secondly,
the pasteurized milk was pre-fermented for 24 hours at
30°C with the propionibacteria (inoculum levels of 0, 1,
2, 5, 10 or 20%), before addition of the yoghurt starter
culture. The second phase of fermentation was again 16
hours at 30°C. At the end of fermentation the pH and via-
ble counts were determined and the riboflavin content of
the yoghurt was measured.
Nucleotide sequence accession numbers
The nucleotide sequence data of the 5' leader regions
upstream of the riboflavin biosynthesis operons in Lc.
mesenteroides NCDO 2028 and Lb. plantarum NCDO 1752
reported in this paper have been submitted to the Gen-
bank database under accession numbers DQ645591 and
DQ645592 respectively.
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Table 1: Strains and plasmids used in this study
Strains and plasmids Details Reference
Strains
Lc. mesenteroides NCDO2028 Beetroot silage isolate UCC culture collection
Lc. mesenteroides CB200 to CB210 NCDO2028 derivatives that are resistant to roseoflavin This study
Lb. plantarum WCFS1 Sequenced strain [33]
Lb. plantarum NCDO1752 Pickled cabbage isolate UCC culture collection
Lb. plantarum CB300 to CB305 NCDO1752 derivatives that are resistant to roseoflavin This study
P. freudenreichii NIZO B374 CBS115915, formerly subsp. shermanii, now subsp. freudenreichii; 
cheese isolate
NIZO culture collection
P. freudenreichii NIZO B2336 Roseoflavin resistant derivative of strain NIZO B374 This study
P. freudenreichii NIZO B374.21 Roseoflavin resistant derivative of strain NIZO B374 This study
P. freudenreichii NIZO B369 CBS115914; From Eidg. Milchw. Versuchsanstalt. Liebefeld NIZO culture collection
P. freudenreichii NIZO B2663 to NIZO B2672 Roseoflavin resistant derivatives of strain NIZO B369 This study
(A) Final pH of yoghurt with various inoculum levels of P. freude reichii B374 or B2336 either added 24 hours before-han  o  simultaneously ith the yoghurt starter cu tureFigure 8
(A) Final pH of yoghurt with various inoculum levels of P. 
freudenreichii B374 or B2336 either added 24 hours before-
hand or simultaneously with the yoghurt starter culture. (B) 
Final riboflavin levels in yoghurt with various inoculum levels 
of P. freudenreichii B374 or B2336 either added sequentially 
or simultaneously with the yoghurt starter culture.
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